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                                                               ABSTRACT 
TITLE: Staging of Laryngeal Cancer Endoscopy & Radiology Versus 
Histopathology 
BACKGROUND: clinical staging with the help of history, examination and video 
direct laryngoscopy have not been able to be accurate. Gross underestimation of 
cases and small percent of over estimation of staging occurs. This leads to 
inappropriate management of cases . With the help of CT underestimation of cases 
have lowered down considerably and a proper management protocol could be 
arrived. 
OBSERVATION AND RESULTS : Clinical staging accuracy is only 33% and Ct 
staging accuracy with clinical staging is 83%. Thyroid cartilage involvement is 
identified accurately in 73% by CT. Anterior commissure involvement is identified 
in 100 % of cases. No early nodal metastasis is identified in clinically NO neck 
which have produced recurrence. 
CONCLUSION: The accuracy of clinical staging in our study of advanced stage 
laryngeal tumours  decreased from supraglottic to glottic to transglottic tumours. 
Conversely, the staging accuracy of sectional imaging is best in transglottic 
tumours and similar supraglottic tumours  and glottic tumours. 
 There is gross underestimation of T4a cases clinically, almost 67% . With the help 
of CT underestimation of T4a cases have come down to 17%. CT therefore 
prevented most of the clinically underestimated cases from undergoing 
unnecessary organ preservation modalities like chemoradiotherapy and then 
salvage Total Laryngectomy. Further CT helped in identifying thyroid  cartilage 
invasion accurately in 73%  
of cases which has aided immensely in treatment planning. With addition of MRI,  
accuracy could still improve and aid in reducing underestimation of cases. Early 
nodal metastasis is missed by CT. 
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INTRODUCTION 
Studies in surgical pathology with whole organ sectioning of  
laryngectomy specimens  have greatly improved the understanding of the 
biological behaviour and the patterns of spread of laryngeal cancer. Over 
the years, a wide range of partial laryngectomy procedures have evolved 
to include lesions located at different sites and of varied extent , within 
the scope of conservation laryngeal surgery. Just twenty years ago , one 
considered partial laryngectomy only for early  laryngeal cancer. Today 
the range procedures is wide enough to include even advanced laryngeal 
cancer within its scope. 
Advances in the imaging technology  by way of  CT and MRI 
scanning have contributed further to the success of the voice conservation 
procedures by accurately determining the extent of the lesions . These 
sophisticated imaging techniques judge the depth of the tumour and 
determine the tumour volume factors which are crucial in the selection of 
the treatment modality. 
The ability to achieve uniform dose curves has made radiation 
therapy a safe undertaking for early lesions of the anterior commissure. 
For more advanced lesions and large volume disease, where radiation 
therapy hitherto had only limited success, trials with hyper fractionated 
treatment to achieve better control rates are progressing. 
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The comparison of the end results of treatment with different  
modalities has been possible with an internationally  standardized TNM 
staging accepted by both the UICC and the AJCC has its own fallacies 
and strength however , is that it is an evolving system. 
Despite all these advances in surgery and radiotherapy, for many 
advanced laryngeal lesions a total laryngectomy, often followed by 
postoperative radiation therapy is the only alternative that offers a 
reasonable chance of cure.  
Treating  such lesions with radical radiation and reserving salvage 
surgery for the failures is a plan that has saved a few larynx  but the cost 
has often been severely compromised cure rates , especially when follow 
ups are poor. 
In India the population – based registry estimates an annual 
incidence of nearly 25,000 new cases of cancer of the larynx . 
Supraglottic cancer is more than twice as common as glottis cancer. 
Marginal zone cancer (aryepiglottic fold and free border of the epiglottis) 
are more  common than cancers of the false cord and the infrahyoid 
epiglottis. 
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Regarding the treatment of laryngeal cancers there are two diverse 
and  disturbing treatment  trends that dominate the Indian scene . On the 
one hand is the heavy leaning and preference for radiation therapy for all 
laryngeal cancers, early and late , since treatment with radiotherapy offers  
laryngeal preservation. on the other hand there is the practice of 
performing total laryngectomy for lesions that would have easily lent 
themselves to a voice conserving surgical procedure it is here that we 
need to strike a balance. 
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REVIEW OF LITERATURE 
Pressman study of compartmentalisation of larynx 
Pressman conducted a study in 1956 and found out that there are 
several compartments in larynx. He also described the lymphatic drainage 
of larynx. He observed that dye injected into ventricle passed above and 
below the glottis deep to the mucosa and confirmed the space lateral to 
the ventricle. Hajeck in 1932 observed that laryngeal edema was 
restricted to localized compartments.  
Pressman elaborated on this observation utilizing the dye which 
was injected under pressure into the larynx. He found that at the level of 
true and false vocal cords, there was a demarcation of larynx. At the level 
of supraglottis dye went into the midline and down to the false vocal 
cords. Dye remained localized in the ventricle when injected except in the 
saccule region and it migrated to opposite side. In the subglottis, dye 
remained in the midline from the true vocal cord to the end of cricoid. At 
the cord level, dye was left in situ for four days to follow its migration. 
Dye migrated to the inner perichondrium, then it was picked up by the 
lymphatics within the inferiorlaryngeal vessels and went through the 
cricothyroid membrane. Pressman further investigated these 
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compartments using phosphate and described seven separate areas as 
following-  
1. Epiglottic region 
2. Marginal epiglottic region 
3. Posterolateral supraglotttic region 
4. Ventricular region including the inferior surface of vestibular band 
and superior surface of vocal cord 
5. Sacciform region  
6. Reinke’s space 
7. Subglottic region 
According to pressman the dyes injected submucosally in the 
supraglottis did not spread interior to the ventricle. Fibroelastic 
membranes within the laryngeal frameworks serves as functional barriers 
and provides anatomic explanation of these findings. 
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Fascial planes of  larynx 
 
 
fig.(1) fascial planes of larynx 
Reinke’s space  
 The is a submucosal space between the mucosa of the glottis and 
the underlying vocalis muscle it acts as a bursa allowing the mucosa to 
slide over the underlying tissues producing  fluency in normal speech . 
Very early glottic cancers remain superficial, rarely penetrating the 
deeper tissues . The mucosa of  the vocal cord can therefore be stripped 
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off without causing damage to the underlying soft  tissues with practically 
no alteration in the quality of voice. 
Preepiglottic space 
The pre-epiglottic space is bound superiorly by the hyoepiglottic 
ligament, anteriorly by the thyroid cartilage and thyrohyoid membrane, 
and posteriorly by the epiglottis and thyro epiglottic ligament. The 
cartilage of the epiglottis has numerous perforations that allow transit of 
tumor from the posterior surface of the epiglottis into the pre epiglottic 
space. Furthermore, dehiscences in the thyrohyoid membrane created by 
the superior laryngeal neurovascular bundle allow extension of tumor 
from the pre-epiglottic space into the neck. 
Paraglottic space 
Alternatively, tumor may invade in a cephalad-caudal spread via 
the paraglottic space into all the subsites of the larynx . The paraglottis 
space is a potential space, and together with the pre-epiglottic space 
forms, a horseshoe-shaped fatty space around the internal laryngeal 
structures. The lateral boundaries of the paraglottic space are the thyroid 
cartilage anteriorly and the mucosa overlying the medial wall of the 
piriform sinus posteriorly.  
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Superiorly and medially lie the quadrangular membrane, and the 
conus elasticus is situated inferiorly. Involvement of the paraglottic space 
by tumor allows fascial free access to the supraglottic, glottic, and 
subglottic regions in addition to the soft tissues of the neck.  
PATTERN OF TUMOUR SPREAD 
Supraglottic tumours  
Supraglottic tumours spread preferentially in an upward direction 
towards the base of the base of the tongue and rarely involve the larynx 
below the ventricle. This unique pattern of tumour spread renders these 
tumours suitable for the supraglottic  partial laryngectomy . Cancers 
within each subsite of the supraglottis are distinct in terms of tumour 
spread and management. 
Epiglottic tumours: 
Clinically the epiglottis is divided into a suprahyoid and an 
infrahyoid part , with reference to the level of the hyoid bone . Tumours 
are proliferative masses with minimal underlying invasion, these tumours 
tend to be over staged because of their size and ball- valve like 
obstruction of the airway. If the base or pedicle is narrow they are 
eminently suitable for endoscopic laser excision. 
9 
 
Tumours  of the infrahyoid  epiglottis are usually deeply infiltrative 
in nature. Infrahyoid epiglottic lesions may also grow circumferentially to 
involve the false cords, aryepiglottic fold. Pre epiglottic space 
involvement occurs.  
Bulky pre – epiglottic space masses undergo central necrosis due to 
a relative lack of blood supply and generally respond poorly to 
radiotherapy.Epiglottic  tumours  rarely invade the thyroid cartilage . 
Hence, the perichondrium on the superior border of the thyroid cartilage 
may be safely elevated while performing  a supraglottic laryngectomy. 
Thyroid cartilage invasion occurs late and implies  transglottic spread 
which is an absolute contraindication to supraglottic laryngetomy.  
Tumours of the false cord  
 Cancer of the false cord or ventricular fold are relative uncommon. 
Tumours from  this region spread upwards to involve epiglottis . 
Posteriorly to involve  the aryepiglottic fold and arytenoids  and inferiorly  
to involve anterior  commissure . The anterior commissure acts as a 
barrier to inferior spread. If this is breached there is a high chance of 
thyroid involvement. 
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fig.(3) supraglottic tumour through paraglottic space rendering the 
tumour transglottic 
Tumours of the ventricle  
Pure ventricular tumours are extremely rare. The true extent of 
tumour spread is difficult to evaluate as these tumours invade the 
paraglottic space early, with significant submucous extension, and what is 
visible on endoscopy may be the proverbial ‘tip of the iceberg ‘most of 
these tumours are transglottic  at presentation . The perichondrium of the 
thyroid cartilage is infiltrated early and later the cartilage itself  . Invasion 
of the pre – epiglottic space and infrahyoid  epiglottis is common. Any 
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tumour crossing the ventricle in the vertical plane is transglottic . There 
may be submucous extension onto the medial wall  of the pyriform fossa. 
Tumours of the arytenoids and aryepiglottic fold  
 Lesions confined purely to the arytenoids and aryepiglottic fold 
are uncommon. Cancers in this area usually spill into the adjacent 
pyriform fossa or post cricoids early in the course of the disease they 
behave differently from other cancers in the supraglottic  larynx and are 
more like pyriform fossa tumours . These lesions are common in india 
and are also referred to as marginal zone cancers. 
Glottic tumours 
Glottis lesions are a heterogenous group of disorders starting from 
a keratotic lesion, progressing through various grades of atypia (mild, 
moderate , severe) to an in-situ carcinoma and finally invasive cancer . In 
– situ carcinoma is limited by the basement membrane of the mucosa. 
Most glottis cancers arise in the free margin of the anterior two thirds of 
the vocal cord . Initial spread occurs horizontally towards the anterior 
commissure. 
Very early cancers are limited to the mucosa without involvement 
of the underlying muscle because of  reinke’s space, as the anterior 
commissure is reached, a dense mass of fibroelastic tissue  
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(thyroepiglottic ligament , conus elasticus and inner perinchondrium of 
the  thyroid ala) prevent further spread Vertical spread of the tumour 
upstages it to T2  and is usually subglottic. inferior spread  is limited by 
the conus  elasticus which is a barrier between the glottis and subglottis. 
This tough membrane is weakest at point where neurovascular bundles 
enter or exit the larynx. Deep lateral invasion occurs in the paraglottic 
space with infiltration of the thyroarytenoid muscle and vocal cord  
fixation. Contiguous spread eventually leads to invasion of the ossified or 
calcified lower border of the thyroid ala and outside the  larynx through 
the cricothyroid membrane into the strap muscles and thyroid gland . The 
common may extend superiorly in to the false cord and aryepiglottic old 
(glottis carcinorna with supraglottic extension).The degree of subglottic 
extension   is vital in planning a conservative vertical hemilaryngectomy . 
The critical cut off  level is limited to the cricoids cartilage which lies 
10mm anteriorly and 5mm posteriorly. Primary posterior lesions of the 
glottis are rare however , the posterior commissure is  frequently involved 
by advanced tumours from other sites . There is rapid invasion of the 
arytenoids , cricoarytenoid joint and cricoids cartilage . The paraglottic 
space is then invaded and  tumour extends vertically downwards towards 
the cricothyroid joint. Lateral spread occurs submucosally to involve the 
apex of the pyriform fossa. 
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Anterior commissure lesions 
Primary tumours of the anterior commissure are uncommon . The 
anterior Commissure is usually involved by secondary spread when a 
membranous cord lesion extends across the midline. The anterior 
commissure is directly  attached to the thyroid cartilage without  
intervening issues by the broyle’s tendon. Early invasion of the cartilage 
is , therefore , common in these tumours. Tumour spread superiorly , 
involves the base of the epiglottis while inferiorly  the tumour exit the 
cricothyroid  memberane and involves the soft tissues of the neck. At one 
time , patients with glottis lesions involving the anterior commissure were 
generally advised to undergo surgery because of the fear of early of early 
cartilage invasion  and consequently poor radiotherapeutic response. 
However  , kirschner’s study points out that the mass of fibroelastic  
tissue at the anterior commissure offers a dense barrier to the spread of 
early glottis cancer  . It is now recognized that stage for stage the anterior 
commissure is not any more readily invaded than any other part of the 
larynx .  
The pattern of tumour  growth at the anterior commissure indicates  
the propensity to invasion of the thyroid cartilage . If   tumour extent 
from the vocal Cord onto the lower portion  of the epiglottis at the 
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anterior commissure , the risk of thyroid cartilage invasion is extremely 
great . 
Glottic cancers crossing the anterior commissure onto the opposite 
cord can be Treated with an extended  hemilaryngectomy. This is feasible 
if at least one half Of the remaining true cord can be preserved . 
Subglottic tumours  
Subglottic  tumours  are rare and account for less than one per cent 
of all Laryngeal tumours. Tumour spread occurs bilaterally and along the 
entire Circumference of the subglottis . The cricoids cartilage is involved 
early because of the absence of an  intervening muscle layer . Fixity of 
the true vocal cords is usually the presenting feature.  
Transglottic tumour  
     Tumors that invove both supraglottis and glottis across the 
ventricle and Cause cord fixation are defined as transglottic cancers.  
They are important because they usually present as advanced with the 
cartilage invasion, extralaryngeal spread or involvement of opposite side 
and therefore are treated by near total or more often, a total laryngectomy.  
Tumors of supraglottis can occassionally become transglottic by spread 
onto the anterior commissure.  These tumors are highly aggressive and 
invade cartilage early.   Supra glottic or Glottic tumors with posterior 
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extension become transglottic by spread on to the cricoarytenoid joint or 
the inter arytenoid area.  Extra laryngeal spread occurs Through the 
thyroid cartilage, the cricothyroid membrane or the thyrohyoid 
Membrane.  
Tumor  thickness  as  a  prognosticator 
 Tumor  thickness  has  been  indirectly  correlated  with  prognosis  
in  laryngeal  cancer.  A  retrospective  study  of  111  T1-3  laryngeal  
cancer  patients  treated  with  surgery  found  tumor  thickness  was  
significantly  related  to  T,  N,  and  clinical  stage  as  well  as pathologic  
cervical  lymphnode  metastasis,  cartilage  invasion,  microscopic  
appearance,  perineural  invasion,  and  lymphatic  invasion .  Dadas  and  
colleagues    proved  the  feasibility  of  intraoperative  assessment  of  
tumor  thickness  in  laryngeal  cancer  patients  by  frozen  section  
analysis. e1F4E,  a  eukaryotic  protein  synthesis  initiation  factor  
elevated  in  almost all  head  and  neck  squamous  cell  cancers,  has  
been  reported  to  be  an even  more  sensitive  prognostic  indicator  for  
local  recurrences  compared with  p53.   
Staging evolution 
The  last  modification  of  the  AJCC TNM  staging  protocol  
occurred  in  2002.  Although  this  staging  provides  prognostic  
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information,  it  does  not  stratify  the  patients  into  the  various  
treatment  modalities  to  assist  the  clinicians.  To  this  end,  the  
American  society  of  clinical  oncology  formed  a  multidisciplinary  
Expert  panel  to  review  the  current  literature  available  through  
November  of  2005.  One  finding  was  the  lack  of  randomized  
prospective  trials  to  direct  evidence-based  treatment  algorithms.  
Regardless,  the  report  did  recommend  that  T1  and  T2  laryngeal  
function  with  should  be  treated  with  the  intent  to  preserve  the  
laryngeal  function  with  a  single  modality.  For  most  T3  and  T4  
without  extensive  cartilage  invasion,  an  organ- preservation  modality  
is  an  appropriate  and  standard  treatment  option.  However,  no  organ- 
Conservation  modality  offered  a  survival  advantage  in  comparison  
to  total  Laryngectomy. 
IMAGING ANATOMY OF LARYNX 
Supraglottis 
 
The supraglottic larynx is delimited inferiorly by the superior 
surface of the true vocal cords. On cross-sectional imaging, the false 
vocal folds are easily discriminated from the true cords by submucosal 
presence of fat in the former. The pre-epiglottic space is filled with fat 
tissue . Robust lymphatic drainage to the high deep cervical chain 
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contributes to the higher incidence of nodal metastasis at the time of 
diagnosis of lesions in this region. 
Glottis 
The vocal folds (true vocal cords) ,anterior and posterior 
commissures comprise the glottis . Radiologically, the vocal folds are 
easily distinguished from the false vocal cords by the presence of 
submucosal soft tissue density attributable to the vocalis muscle. 
Lymphatic drainage from the glottis itself is sparse, and nodal metastasis 
from lesions in this region is rare. 
 
 
Fig. 1. Axial CT images from the supraglottic (A), glottic (B), and 
subglottic 
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(C) levels.  
(A) Note that submucosal fat (long arrow) is seen in the supraglottic 
level. The short arrow points to the arytenoid cartilage. 
(B)  No submucosal fat is apparent at the level of glottis because of the 
thyroarytenoid muscle (arrow).  
C)  There is no submucosal tissue in the subglottis at the level of the 
cricoid ring so that the air column abuts the cartilage (arrows). 
.  
Fig. 2. Axial CT image through the glottis. 
Arrows point to the anterior commissure (A) andthe posterior 
commissure. (B) Note lack of submucosal tissue in these regions.  
(C) Sagittal CT shows the pre-epiglottic space (arrow) as a dark 
area because of low x-ray attenuation of fat. 
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Subglottis 
The endoluminal contour of the subglottis is normally smooth . The 
presence of subglottic soft tissue should raise suspicion of neoplastic 
invasion. Lymphatic drainage from the subglottis is sparse, and nodal 
metastasis from lesions in this region is rare. 
Choosing modality of imaging 
CT versus MRI 
Multichannel CT affords high spatial resolution images that can be 
reformatted in any desired plane, essentially negating the traditional 
advantage of MRI because of its multiplanar capability. Superior contrast 
resolution and multiparametric imaging (eg, T1-weighted, T2-weighted) 
remain significant advantages of MRI. 
CT evaluation is much faster than MRI, substantially reducing or 
eliminating artifacts of movement attributable to breathing, swallowing, 
or coughing. MRI is more resource-intensive and less available than CT. 
Overall, the staging accuracy of MRI in laryngeal cancer is slightly 
higher, largely because of more accurate assessment of cartilage 
involvement and paraglottic, pre-epiglottic extension of tumor. CT is still 
more commonly used compared with MRI for initial staging of laryngeal 
cancer because of practical advantages, such as cost, speed, and 
availability. 
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Positron emission tomography–CT 
Studies with sufficiently large numbers of patients investigating the 
role of positron emission tomography (PET)–CT in staging of laryngeal 
cancer are lacking. Recent reports  by study of  “Pohar S, Brown R, 
Newman N, et al. 2007”   suggest that PET evaluation of head and neck 
cancers may not present sufficient sensitivity or specificity to justify its 
routine use at the time of initial diagnosis , whereas others have reported 
that it significantly altered treatment in a substantial number of patients. 
RADIOLOGICAL EVALUATION OF LARYNGEAL 
CANCER 
Pre-epiglottic and paraglottic space invasion 
The pre-epiglottic space is readily identified on non contrast T1-
weighted MRI or CT, particularly in the sagittal plane, because of its 
largely fatty contents. On either side, the pre-epiglottic space is 
continuous with the paraglottic  space (also known as the paralaryngeal 
space). The para glottic space spans between the thyrohyoid membrane, 
thyroid and cricoid cartilages laterally and between the false and true 
vocal cords and the elastic cone medially. It contains fat at the level of the 
false vocal cords. This can be easily identified on axial and sagittal non 
contrast T1-weighted MRI and CT, because fat tissue has unique imaging 
features. Invasion of the pre-epiglottic fat by glottic or supraglottic 
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carcinomas is difficult to appreciate on clinical examination but is often 
readily appreciated by the head and neck radiologist as replacement of the 
normal fat on CT or MRI .”Loevner LA, Yousem DM, Montone KT, et 
al. 1997.” did a study on this and showed above facts. 
Anterior and posterior commissures  
Between the attachment sites of the vocal cords to the thyroid 
cartilage is a ‘‘bare’’area, wherein the laryngeal mucosa abuts the thyroid 
cartilage. This is known as the anterior commissure. The mucosa 
covering the posterior wall of the glottis between the arytenoid cartilages 
is known as the posterior commissure. There is no submucosal tissue 
present in the anterior and posterior commissures, which are bounded by 
air inside and cartilage outside, simplifying the detection of tumor 
involvement. If no tissue is seen in these regions, tumor  extension can 
reliably be excluded. When there is visible soft tissue in the  region of 
the anterior or posterior commissure, tumor infiltration is considered, 
although  physiologic apposition of the vocal cords and edema can give 
similar appearance. Simple bulging of the vocal cord mass into these 
regions should not be overinterpreted as invasion . Endoscopic evaluation 
of the mucosal extent of disease in the anterior and posterior commissures 
is more reliable than imaging, however, submucosal extent, particularly 
in the form of thyroid cartilage invasion or extension through the 
cricothyroid membrane, is common once the anterior commissure is 
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involved and often escapes clinical detection . Extension of a vocal cord 
tumor to the anterior commissure does not change the T-staging but may 
affect survival and choice of treatment method, because surgical exposure 
of this region with endoscopic tools may be challenging and vertical 
laryngectomies would require a more extended approach. Involvement of 
the posterior commissure constitutes a contraindication for supracricoid 
partial laryngectomy. 
 
Axial CT images through the supraglottis (A, B) and the glottis (C). 
There is a bulky supraglottic mass with involvement of the pre-
epiglottic and paraglottic spaces (arrows in A and B). At the level of the 
glottis (arrows in C), no abnormal tissue is seen; tumor is confined to the 
supraglottic larynx (T3) and is amenable to partial supraglottic 
laryngectomy. 
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Subglottic spread 
Imaging plays an essential role in assessment for subglottic spread 
of disease, because this region is difficult to evaluate endoscopically. 
Imaging with CT or MRI can reliably identify subglottic extension, 
because the subglottis normally is lined by a thin layer of mucosa. Any 
additional soft tissue in this region should be treated as suspicious for 
neoplastic involvement. This evaluation is easier in the coronal plane but 
can be accomplished with similar accuracy in the axial plane . The conus 
elasticus, a tough collagenous   membrane, extends from the true vocal 
cord to the superior margin of the cricoid cartilage and forms the lower 
border of the paraglottic space. As a  barrier to the spread of tumor, the 
conus elasticus diverts submucosal tumor extension laterally, away from 
the cricoid cartilage. Likewise, tumors spreading along the mucosa 
usually spare the paraglottic region in the subglottis because of the conus 
elasticus.  
Once tumor extends below the conus elasticus, it can infiltrate the 
cricoid cartilage with relative ease, making it necessary to perform a total 
laryngectomy. Thus, it is critical to assess tumor extent in relation to the 
superior ring of the cricoid cartilage . Visualizing tumor within the 
cricoid ring is a clear indication of subglottic  extension. Craniocaudal 
tumor extent below the free edge of the true vocal cord of 10 mm 
anteriorly and 5 mm posteriorly can be tolerated.  
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Fig. (A, B) Axial CT images show asymmetric fullness of the right 
true vocal cord and the anterior commissure (long arrows), giving the 
impression that the tumor extends to the anterior commissure. 
(B) Short arrow points to the pyramidal lobe of the thyroid, 
mimicking extralaryngeal extension of glottic cancer.  
(C) MRI shows the anterior extent of tumor (arrow) without
 involvement of the anterior commissure.  
Cartilaginous invasion 
Cartilaginous invasion limits the probability of adequate response 
to radiation and increases the probability of radiation-induced necrosis. 
cartilage invasion increases radiation induced necrosis. Therefore, the 
presence or absence of cartilaginous invasion is an important data point 
for therapeutic decision making, and the presence of cartilaginous 
25 
 
invasion often justifies extensive surgery that might not be undertaken 
otherwise. Because the cartilaginous structures are largely inaccessible to 
clinical examination, assessment of the possibility of cartilaginous 
invasion before treatment is the responsibility of  the radiologist. 
Unfortunately, the imaging characteristics of  hyaline cartilage are 
variable. Ossification of the cartilaginous structures of the larynx 
increases with age but varies and may be asymmetric. Whereas ossified 
cartilage demonstrates high attenuation on CT at the outer and inner 
cortices with relatively lower attenuation, medullary space nonossified 
cartilage demonstrates attenuation similar to that of other soft tissue 
structures. On MRI,the cortical signal depends on the presence or absence 
of calcification, andthe fatty medullary signal demonstrates T1 
hyperintensity with intermediate signal on T2-weighted images. This 
variability can complicate imaging evaluation because of corresponding 
inhomogeneity of density and signal on CT and MRI, respectively, 
presenting a challenge to noninvasive evaluation. 
Further complicating matters, reactive changes within cartilage 
may occur without the presence of neoplastic invasion, resulting in 
overestimation of disease extent, particularly with MRI. Regardless, 
contrast enhancement is not a normal feature of cartilage on MRI or CT . 
Either technique should be able to aid in the differentiation of inner 
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cortical invasion (T3) from involvement of inner and outer cortices and 
extralaryngeal spread (T4). 
As noted in the preceding phrases, MRI allows for excellent soft 
tissue contrast and has been viewed as superior to CT for detection of 
cartilaginous invasion. MRI demonstrates increased T2 signal and low to 
intermediate  T1 signal, with abnormal enhancement in cases of 
replacement of infiltration of hyaline cartilage. Although these signs are 
quite sensitive, inflammatory and reactive peritumoral changes may have 
an identical appearance, limiting specificity. Some investigators suggest 
that inflammatory reaction may be distinguished by greater T2 signal . 
Given the inherent sensitivity of MRI and consequent high negative 
predictive value, it has generally been preferred over CT at the time of 
initial evaluation .  
Becker and colleagues studied the CT evaluations of 111 patients 
and describe CT signs with high specificity, including the presence of 
lysis or erosion (93% specificity) or extralaryngeal spread of neoplasm 
(95%) specificity. Because these signs depend on relatively advanced 
disease, their sensitivity is understandably low. Conversely, the presence 
of sclerosis within a cartilaginous structure is relatively sensitive, but the 
specificity of this sign varies with location, being lower in the thyroid 
cartilage (40% specificity) than in the cricoid and arytenoid cartilages 
(76%–79% specificity). 
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Fig. . Glottic cancer with subglottic extension and cartilage 
involvement. (A–C)  
Three axial CT images with a soft tissue window reveal subglottic 
extension of patient’s glottic tumor.(C) Identification of tumor within the 
cricoid ring (arrows) indicates subglottic extension and a need for total 
laryngectomy.  
Normally, there should not be any soft tissue thicker than 1mm in 
this region. (D) Axial CT image with a bone window through the level of 
the thyroid cartilage shows erosion of the inner cortex of the cartilage 
(arrow) over a large area, indicating tumor extent. Compare with the 
smooth surface of the right thyroid ala 
 
. 
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Fig. Transglottic tumor with thyroid and arytenoid cartilage 
invasion. Axial CT images show paraglottic (A), glottic (B, D), and 
subglottic (C) tumor extension.  
(A) At the supraglottic level there is a soft tissue mass (arrow) 
replacing the paraglottic fat. (B)At the level of the glottis, tumor grows 
posteriorly to the posterior commissure. Note sclerosis of the arytenoid 
cartilage, indicating invasion (long arrow). Medial displacement of the 
arytenoid suggests cricoarytenoid involvement. The anterior commissure 
is spared (short arrow).  
Extension of tumor to the subglottic level is obvious on imaging as 
normally no soft tissue thicker than 1mm is seen in this region. There is a 
focal lytic lesion in the inner surface of the thyroid cartilage (arrow) on 
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bone windows that corresponded to through-andthrough cartilage 
involvement on pathologic examination. 
Prevertebral involvement 
Involvement of the prevertebral fascia by tumor renders the tumor 
unresectable. 
Unfortunately, the determination of prevertebral involvement is 
best achieved by intraoperative observation. Radiologic detection of 
prevertebral involvement is problematic. There is a small amount of fat 
tissue within the retropharyngeal space that can be identified on MRI and 
CT in most individuals. A lack of obliteration of this fat plane is a good 
indicator for lack of prevertebral involvement . Obliteration of the fat 
plane, conversely, does not reliably predict prevertebral tumor 
involvement unless obvious tumor bulk is present. 
Carotid artery involvement 
Unless the carotid artery is resected, extralaryngeal spread of tumor 
to infiltrate carotid artery renders the tumor inoperable. Not all tumors 
abutting the carotid infiltrate the adventitia, however. The determination 
of resectable from unresectable tumors relies heavily on imaging 
findings. If tumor contacts more than 270* of the circumference of the 
carotid, the likelihood of invasion is high and these tumors are deemed 
unresectable.  Contact less than 180*  has a low likelihood of tumor 
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invasion.  In cases with contact 180 *and 270*, the radiologic distinction 
is not as reliable. 
Radiologic findings and the choice of method of treatment  
Patient preference has a significant bearing on the type of treatment 
chosen. In era of an increasing variety of treatment options, including 
traditional surgical, minimally invasive, and nonsurgical options with 
voice-conserving approaches, the assessment of tumor extent with respect 
to certain critical structures that affect the treatment method has become 
even more important. Virtually all surgical and nonsurgical procedures 
can be modified depending on the special circumstances of each tumor. 
Stage 4a tumors are generally considered resectable, whereas stage 4b 
tumors are not . Prevertebral or mediastinal extension and invasion of the 
carotid artery upgrade tumors to T4b. The  negative predictive value of 
preservation of retropharyngeal fat signal on MRI  for prevertebral 
involvement is greater than 90%. Unfortunately, the positive predictive 
value of loss of retropharyngeal fat signal is approximately 60%.  
Thus, overall imaging diagnosis of lack of prevertebral 
involvement is reliable, whereas unless there is gross tumor in this region, 
the presence of prevertebral involvement is not. 
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Horizontal supraglottic partial laryngectomy 
A horizontal supraglottic partial laryngectomy (SPL) can be 
performed for many supraglottic cancers. This procedure spares the 
arytenoids and true vocal cords and removes the supraglottic structures, 
including a portion of the thyroid cartilage, with the plane of resection at 
the level of the laryngeal ventricles. Tumor extension below the laryngeal 
ventricle and substantial cartilage involvement would contraindicate this 
surgical procedure .  
Supracricoid partial laryngectomy with cricohyoido(epiglotto)pexy 
If there is transglottic extension of a supraglottic cancer or supraglottic 
extension of cricohyoido(epiglotto)pexy [SCPL CH(E)P] procedure may 
be an option. Although the functional outcome of this procedure is not as 
good as that of SPL, it may be the only alternative to total laryngectomy. 
SCPL CH(E)P preserves at least one of the arytenoids. Contraindications 
to this surgical procedure include bilateral arytenoid involvement, 
posterior commissure disease, hyoid bone involvement, and subglottic 
extension beyond the upper margin of the cricoid ring. Invasion of the 
pre-epiglottic space is a contraindication  for SCPL CH(E)P but not for 
supracricoid partial laryngectomy with cricohyoidopexy (SCPL CHP) .  
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Vertical hemilaryngectomy 
When the tumor is confined to one side of the larynx, a vertical 
hemilaryngectomy may be performed. This surgical procedure removes 
the ipsilateral cord and up to the anterior one third of the contralateral 
cord as necessary. Determination of the presence and degree of extension 
across the anterior commissure is critical in this scenario. 
Contraindications include involvement greater than the anterior one third 
of the contralateral cord, cricoarytenoid joint involvement, and subglottic 
extension below the upper margin of the cricoid ring .  
Lymphatic drainage of the larynx and nodal metastasis 
With a single lymph node involved by metastatic disease, the 
prognosis is said to be reduced by half. Criteria that suggest metastatic 
involvement of a lymph node include enlarged size, abnormal shape, 
necrosis, and extracapsular spread. The sensitivity of CT and MRI in 
detecting nodal metastasis is higher than clinical examination and lower 
than PET. Unfortunately, the negative predictive value of imaging, 
including PET, is not sufficiently high to reassure the surgeon and avoid 
neck dissection.  
Decisions regarding neck dissection in lesions staged as N0 (by 
imaging and examination) depend on the presumed risk for nodal 
metastasis and the comfort level of the surgeon and patient. The risk for 
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nodal metastasis can be estimated on the basis of the site, depth, and 
extent of the primary tumor. A higher N-grading score is associated with 
a higher rate of treatment failure. Extranodal extension predicts a worse 
outcome independent of the N-grading score. For glottic cancer, large 
tumor volume, anterior  commissure involvement,ventricle involvement, 
and cartilage involvement are associated with higher rates of  treatment 
failure. The only independent risk factor that is consistent among studies 
is cartilage involvement, which is identified by CT as inner cortex 
irregularity and by MRI as signal change.  
One study classified glottic tumors as being adjacent to and away 
from the thyroid cartilage inner cortex and demonstrated a worse local 
control rate for the lesions that contact the cartilage independent of the 
status of  cortical irregularity . The study done by “Murakami R, 
Furusawa M, Baba Y, et al. 2000” 
PRIMARY AND SALVAGE TOTAL LARYNGECTOMY 
The results of early laryngectomies of previous century were 
disastrous because of aspiration, pneumonia, hemorrhage, sepsis, 
mediastinitis, and fistula formation . In 1892, Solis-Cohen devised the 
principle of suturing the trachea to the skin . Also in the late nineteenth 
century, Gluck and Sorensen added to the principle of diverting the 
trachea to the skin and introduced primary  reconstruction of the 
pharynx. Over time, not only has the procedure of TL been modified, but 
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there is also an increasing emphasis on voice and swallowing 
preservation and. In 1980, Singer and Blom introduced the 
tracheoesophageal puncture (TEP) and valved prosthesis, restoring 
speech after TL. Eventually, the concept of organ preservation was 
introduced, and partial laryngeal surgical procedures and chemoradiation 
protocols became the treatment of choice when possible. Despite these 
advances, TL still has a role in the treatment of patients who have 
advanced laryngeal cancer. 
Indications 
The indications for a TL have decreased as organ preservation 
strategies have mandated a paradigm shift. In 1991, the Department of 
Veterans Affairs Laryngeal Cancer Study Group demonstrated that 
induction chemotherapy with cisplatin plus fluorouracil followed by 
radiation therapy allowed preservation of the larynx in 64% of patients 
without affecting survival when compared with TL and adjuvant 
radiotherapy . In 2003, Forestiere and colleagues  showed that concurrent 
chemotherapy with cisplatin and radiotherapy resulted in higher laryngeal 
preservation rates, better loco-regional control rate, and similar overall 
survival when compared with induction chemotherapy followed by 
radiation and radiation therapy alone. In this study, patients who had 
large-volume T4 disease, defined as tumors with greater than  1cm 
invasion of the base of tongue or gross cartilage invasion, were excluded. 
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Primary TL  
Indicated in advanced disease that is not amenable to partial 
laryngectomy, concurrent chemoradiation, or radiotherapy alone. 
Specifically, tumors that  penetrated through cartilage, invasion into the 
extralaryngeal soft tissue of the neck, and extensive involvement of the 
base of tongue are suitable for this procedure.  
Non-neoplastic indications 
Include laryngeal dysfunction with life-threatening aspiration or 
chondro-radionecrosis of the larynx. Also, pulmonary status and medical 
comorbidities, cognitive function may define the treatment options for a 
given patient. 
Salvage TL  
 Indicated for chemoradiation, radiation, or partial laryngeal 
surgical failures.  
Salvage laryngectomy was required in 16% of patients treated with 
concurrent chemoradiation and 31% of patients treated with radiotherapy 
alone . Salvage TL can be technically more difficult and carries a higher 
postoperative complication rate. 
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MANAGEMENT OF NECK 
The larynx drains into levels 2 to 4 pretracheal and paratracheal 
lymph nodes within the neck. Advanced laryngeal cancers have an 
overall 30% of occult neck metastasis . Patients who have supraglottic 
and advanced glottic with clinically N0 neck should undergo elective 
treatment of the neck by either neck dissection or radiotherapy . 
Supraglottic tumors have a significant propensity for bilateral neck 
metastasis, and bilateral necks should be addressed . Patients with N1 
disease who are treated with definitive chemoradiotherapy require a neck 
dissection for incomplete clinical response .  
Neck dissection arguably is required for patients with N2 or N3 
disease who are treated with definitive chemoradiotherapy . For salvage 
surgery, the decision to perform a neck dissection should be based on CT 
staging of the neck, as most patients who are radiologically staged N0 are 
unlikely to harbor occult nodal disease.                                
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AIMS & OBJECTIVES 
AIM                                                      
  To evaluate the accuracy of staging of advanced laryngeal cancer 
done in patients who underwent total laryngectomy by comparing 
staging by endoscopy &radiology with histopathology  
OBJECTIVES  
 1. To evaluate clinically underestimated case 
2. To evaluate & analyse cartilage involvement radiologically & 
histopathologically & to device predictive indicators of cartilage 
involvement preoperatively  if possible 
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MATERIALS 
STUDY PLACE : Rajiv Gandhi Government 
General Hospital,  
Chennai – 600003. 
COLLABORATING DEPARTMENT : Upgraded Institute of  
otorhinolaryngology                                                          
STUDY DESIGN : prospective and retrospective 
STUDY PERIOD :  AUGUST 2011 TO OCTOBER 
2013 
ETHICAL CLEARANCE : obtained 
INCLUSION CRITERIA   
All cases of laryngeal cancer who underwent  total laryngectomy 
with or without neck dissection / total or hemithyroidectomy  which 
includes radio recurrent cases and primary cases .                                                             
EXCLUSION CRITERIA  
Patients who underwent total laryngopharyngo oesophagectomy 
and total laryngopharyngectomy.  
 
39 
 
INVESTIGATION: 
1.Endoscopy 
2.Direct Laryngoscopy  
3.computed tomography 
4. ultrasound neck 
5. Fnac of neck node 
6. biopsy of the specimen preoperatively 
7. histopathological analysis of  node and specimen                    
postoperatively 
8. complete blood investigations  
DATA COLLECTION :                  Clinical 
BENEFIT TO THE COMMUNITY :  
1.Improved treatment protocol for  advanced  Laryngeal cancer patients . 
2.Management of neck more effectively in laryngeal cancer patients. 
3.Improve the possibility of voice conservation procedures. 
  
40 
 
CONFLICT OF INTEREST : NIL 
FINANCIAL SUPPORT  : NIL 
PRINCIPAL INVESTIGATOR : Dr. S.Vignesh MS (ENT) 
post graduate   
  
41 
 
METHODOLOGY 
The study was conducted in the tertiary care Rajiv Gandhi 
Government general hospital and madras medical college in the 
department of upgraded institute of otorhinolaryngology. 
Patients with advanced stages of laryngeal cancer who came to 
upgraded institute of otorhinolaryngology are evaluated. Supraglottic . 
transglottic ,glottic and subglottic tumours, radiorecurrent tumours  are 
staged clinically with help of endoscopy. 
 
Fig shows T3 supraglottic cancer taken during operative endoscopy 
Patients who are staged T3/T4a clinically with or without 
secondaries neck are sent for radiological examination .  CT is done in all 
cases . MRI not done. Chest xray , usg neck & abdomen to asees the neck 
nodes and Second primaries. Radiological staging of laryngeal cancer 
done.  
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Fig shows cartilage involvement and extralaryngeal spread 
 
patients with or without tracheostomy prior  with their informed 
consent if fit for surgery are taken up for total laryngectomy with or 
without neck dissection. 
Site of tracheostomy (high, mid, low) if done are not taken in to 
study as variables. Most of the ( Clinical & radiologically) T3 cases with 
taken for laryngectomy  had opposite side of laryngeal involvement.  
Total laryngectomy procedure: 
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Laryngectomy specimen for histopathology sent in every case 
after assessing tumour extension macroscopically    
 
 
Histopathological analysis:  
Whole organ serial sections were studied in axial plane and final 
histopathological staging arrived which is compared with radiological and 
clinical staging ( AJCC , TNM) 
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STATISTICAL ANALYSIS 
 Distribution of the variables was assessed by kolmogrov-smirnov 
tests. Pearson’s chi square was applied to all categorical variables. 
Fischer’s Exact was applied wherever required. Chi square for trends was 
applied for ordinal data. A p value less than 0.05 was taken as significant.  
SPSS version16.0 was used for analysis. 
Frequency Tables and analysis 
Total no. of cases of  total laryngectomy - 31 
 
Mean age of patients  who underwent laryngectomy – 55 yrs 
 
 
Sex
30 96.8 96.8 96.8
1 3.2 3.2 100.0
31 100.0 100.0
Male
Female
Total
Valid
Frequency Percent Valid Percent
Cumulative
Percent
AGE
31 34 67 55.71 9.151
31
Age 
Valid N (listwise) 
N Minimum Maximum Mean Std. Deviation
 Among 31 patients 30 were male and 1 was a female .
TUMOUR LOCATION
 
 
 
 
 
 
0
10
20
30
Yes
No
Total
Valid
Yes
No
Total
Valid
45 
 
 
male female
sex
sex
Supraglottic
10 32.3 32.3 32.3
21 67.7 67.7 100.0
31 100.0 100.0
Frequency Percent Valid Percent
Cumulative
Percent
transglottic
14 45.2 45.2 45.2
17 54.8 54.8 100.0
31 100.0 100.0
Frequency Percent Valid Percent
Cumulative
Percent
 
 
 
The variables were compared in terms of clinical/endoscopic 
staging, radiological staging, histopathological staging. Variables for 
clinical staging are  involvement of arytenoids, marginal zone, subglottis, 
ventricles, extralaryngeal spread, cases that were staged T3 and T4a and 
nodal status.  
Variables that are compared for radiological staging are  
involvement of arytenoids, anterior commissure, thyroid cartilage, cricoid 
cartilage, extralaryngeal spread, T3 and T4a 
variables that are for radiological staging are compared with 
histopathological staging. 
14
Yes 
No 
Total
Valid
46 
staging and nodal status. All 
 
10
7
cases by tumour location
supraglottic
glottic
transglottic
Glottic
7 22.1 22.1 22.1
23 74.2 74.2 100.0
31 100.0 100.0
Frequency Percent Valid Percent
Cumulative
Percent 
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In addition procedures that are done along with total laryngectomy 
like neck dissection, total thyroidectomy and hemithyroidectomy are also 
taken into account.  Also nodal recurrence is also taken as a variable and 
compared with respective tumours along with neck dissection. Here 
radiological variables 
CT are given suffix ® and histopathological variables are given 
prefix (p) .  
Frequency table for variables of clinical evaluation & staging 
 
 
 
 
arytenoid
7 22.6 22.6 22.6
24 77.4 77.4 100.0
31 100.0 100.0
Yes
No
Total
Valid
Frequency Percent Valid Percent
Cumulative
Percent
ant. Commisure
17 54.8 54.8 54.8
14 45.2 45.2 100.0
31 100.0 100.0
Yes
No
Total
Valid
Frequency Percent Valid Percent
Cumulative
Percent
marginal Zone
10 32.3 32.3 32.3
21 67.7 67.7 100.0
31 100.0 100.0
Yes
No
Total
Valid
Frequency Percent Valid Percent
Cumulative
Percent
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ventricle
24 77.4 77.4 77.4
7 22.6 22.6 100.0
31 100.0 100.0
Yes
No
Total
Valid
Frequency Percent Valid Percent
Cumulative
Percent
subglottis
4 12.9 12.9 12.9
27 87.1 87.1 100.0
31 100.0 100.0
Yes
No
Total
Valid
Frequency Percent Valid Percent
Cumulative
Percent
stageT3
30 96.8 96.8 96.8
1 3.2 3.2 100.0
31 100.0 100.0
Yes
No
Total
Valid
Frequency Percent Valid Percent
Cumulative
Percent
stageT4a
1 3.2 3.2 3.2
30 96.8 96.8 100.0
31 100.0 100.0
Yes
No
Total
Valid
Frequency Percent Valid Percent
Cumulative
Percent
Extralaryngeal spread
1 3.2 3.2 3.2 
30 96.8 96.8 100.0
31 100.0 100.0
Yes 
No 
Total
Valid
Frequency Percent Valid Percent
Cumulative
Percent 
Stage T3- 30 cases (96.8%)
Stage T4a- 1 case(3.2%)
N staging by clinical evaluation
 
7
No. of cases staged by clinical 
Yes
No
Total
Valid
Yes
No
Total
Valid
NoValid
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30
evaluation
stage T3
stage T4a
Nodal staging0
30 96.8 96.8 96.8
1 3.2 3.2 100.0
31 100.0 100.0
Frequency Percent Valid Percent
Cumulative
Percent
Nodal staging1
1 3.2 3.2 3.2
30 96.8 96.8 100.0
31 100.0 100.0
Frequency Percent Valid Percent
Cumulative
Percent
Nodal staging2
31 100.0 100.0 100.0
Frequency Percent Valid Percent
Cumulative
Percent
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Total number of cases staged N0-30(96.8%) 
Total number of cases staged N1-1(3.2%) N2-0 
FREQUENCY TABLE FOR PARAMETERS OF RADIOLOGICAL STAGING 
 
 
 
 
arytenoid.R
13 41.9 41.9 41.9
18 58.1 58.1 100.0
31 100.0 100.0
Yes
No
Total
Valid
Frequency Percent Valid Percent
Cumulative
Percent
thyroid.R
18 58.1 58.1 58.1
13 41.9 41.9 100.0
31 100.0 100.0
Yes
No
Total
Valid
Frequency Percent Valid Percent
Cumulative
Percent
cricoid.R
4 12.9 12.9 12.9
27 87.1 87.1 100.0
31 100.0 100.0
Yes
No
Total
Valid
Frequency Percent Valid Percent
Cumulative
Percent
subglottis.R
10 32.3 32.3 32.3
21 67.7 67.7 100.0
31 100.0 100.0
Yes
No
Total
Valid
Frequency Percent Valid Percent
Cumulative
Percent
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Nodal staging with radiological evaluation. 
N0 – 30(96.8) 
N1 – 1(3.2%) 
N2 - 0 
 
 
 
paraglottic.R
25 80.6 80.6 80.6
6 19.4 19.4 100.0
31 100.0 100.0
Yes
No
Total
Valid
Frequency Percent Valid Percent
Cumulative
Percent
preepiglottic sp.R
31 100.0 100.0 100.0NoValid
Frequency Percent Valid Percent
Cumulative
Percent
extralaryngeal spread
2 6.5 6.5 6.5
29 93.5 93.5 100.0
31 100.0 100.0
Yes
No
Total
Valid
Frequency Percent Valid Percent
Cumulative
Percent
Nodal staging1.R
1 3.2 3.2 3.2
30 96.8 96.8 100.0
31 100.0 100.0
Yes
No
Total
Valid
Frequency Percent Valid Percent
Cumulative
Percent
Nodal staging2.R
31 100.0 100.0 100.0NoValid
Frequency Percent Valid Percent
Cumulative
Percent
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T staging with radiological evaluation 
T3-9(29%) 
T4a – 22(71%) 
 
 
 
Selective neck dissection done in 7out of 31 cases 
 
 
stageT3.R
9 29.0 29.0 29.0
22 71.0 71.0 100.0
31 100.0 100.0
Yes
No
Total
Valid
Frequency Percent Valid Percent
Cumulative
Percent
stageT4.R
22 71.0 71.0 71.0
9 29.0 29.0 100.0
31 100.0 100.0
Yes
No
Total
Valid
Frequency Percent Valid Percent
Cumulative
Percent
SND
7 22.6 22.6 22.6
24 77.4 77.4 100.0
31 100.0 100.0
Yes
No
Total
Valid
Frequency Percent Valid Percent
Cumulative
Percent
Total thyroidectomy
30 96.8 96.8 96.8
1 3.2 3.2 100.0
31 100.0 100.0
Yes
No
Total
Valid
Frequency Percent Valid Percent
Cumulative
Percent
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Total no.of cases of total thyroidectomy done- 30/31 (96.8%) 
 
No.of cases of hemithyroidectomy- 1/31 (3.2%) 
Frequency table for histopathological evaluation 
 
Subglottic involvement – 17/31 (54.8) 
 
  
hemithyroidectomy
1 3.2 3.2 3.2
30 96.8 96.8 100.0
31 100.0 100.0
Yes
No
Total
Valid
Frequency Percent Valid Percent
Cumulative
Percent
p ant.comm.H
19 61.3 61.3 61.3
12 38.7 38.7 100.0
31 100.0 100.0
Yes
No
Total
Valid
Frequency Percent Valid Percent
Cumulative
Percent
p subglottis.H
17 54.8 54.8 54.8
14 45.2 45.2 100.0
31 100.0 100.0
Yes
No
Total
Valid
Frequency Percent Valid Percent
Cumulative
Percent
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Paraglottic involvement- 27/31 (87.1%) 
 
 
Thyroid cartilage involvement- 22/31(71%) 
 
Cricoids cartilage involvement- 7/31(22.6%) 
 
Arytenoids involvement-  8/31(25.8) 
p paraglottic.H
27 87.1 87.1 87.1
4 12.9 12.9 100.0
31 100.0 100.0
Yes
No
Total
Valid
Frequency Percent Valid Percent
Cumulative
Percent
p preepiglottic.H
31 100.0 100.0 100.0NoValid
Frequency Percent Valid Percent
Cumulative
Percent
p thyroid .H
22 71.0 71.0 71.0
9 29.0 29.0 100.0
31 100.0 100.0
Yes
No
Total
Valid
Frequency Percent Valid Percent
Cumulative
Percent
p cricoid.H
7 22.6 22.6 22.6
24 77.4 77.4 100.0
31 100.0 100.0
Yes
No
Total
Valid
Frequency Percent Valid Percent
Cumulative
Percent
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Extralaryngeal tissue involvement- 2/31 (6.5%) 
 
Node stage N0- 6/7(85.7%) 
 
Nodal stage N1 – 1/7(14.3%) 
 
 
p arytenoid.H
8 25.8 25.8 25.8
23 74.2 74.2 100.0
31 100.0 100.0
Yes
No
Total
Valid
Frequency Percent Valid Percent
Cumulative
Percent
p extralaryngeal tissues.H
2 6.5 6.5 6.5
29 93.5 93.5 100.0
31 100.0 100.0
Yes
No
Total
Valid
Frequency Percent Valid Percent
Cumulative
Percent
p Nodal staging0.H
6 19.4 85.7 85.7
1 3.2 14.3 100.0
7 22.6 100.0
24 77.4
31 100.0
Yes
No
Total
Valid
SystemMissing
Total
Frequency Percent Valid Percent
Cumulative
Percent
p Nodal staging1.H
1 3.2 14.3 14.3
6 19.4 85.7 100.0
7 22.6 100.0
24 77.4
31 100.0
Yes
No
Total
Valid
SystemMissing
Total
Frequency Percent Valid Percent
Cumulative
Percent
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Nodal stage N2- 0 
 
T stage pT3 – 8/31 (25.8%) 
 
T stage pT4 – 23/8( 74.2%) 
 
Nodal recurrence – 7/31 (22.6%) 
 
  
p Nodal staging2.H
7 22.6 100.0 100.0
24 77.4
31 100.0
NoValid
SystemMissing
Total
Frequency Percent Valid Percent
Cumulative
Percent
staging.PT3
8 25.8 25.8 25.8
23 74.2 74.2 100.0
31 100.0 100.0
Yes
No
Total
Valid
Frequency Percent Valid Percent
Cumulative
Percent
staging.PT4
23 74.2 74.2 74.2
8 25.8 25.8 100.0
31 100.0 100.0
Yes
No
Total
Valid
Frequency Percent Valid Percent
Cumulative
Percent
nodal Recurrence
7 22.6 22.6 22.6
24 77.4 77.4 100.0
31 100.0 100.0
Yes
No
Total
Valid
Frequency Percent Valid Percent
Cumulative
Percent
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Comparison of radiological parameters with histopathology 
 
 
CT in terms of comparison of anterior commissure with 
Histopathology 
Sensitivity – 100% 
Specificity – 66% 
Positive predictive value – 82.6% 
 
ant.comm.R * p ant.comm.H Crosstabulation
19 4 23
61.3% 12.9% 74.2%
0 8 8
.0% 25.8% 25.8%
19 12 31
61.3% 38.7% 100.0%
Count
% of Total
Count
% of Total
Count
% of Total
Yes
No
ant.comm.R
Total
Yes No
p ant.comm.H
Total
Chi-Square Tests
6.718b 1 .010
1.219 1 .270
3.359 1 .067
.127 .127
6.501 1 .011
31
Pearson Chi-Square
Continuity Correction a
Likelihood Ratio
Fisher's Exact Test
Linear-by-Linear
Association
N of Valid Cases
Value df
Asymp. Sig.
(2-sided)
Exact Sig.
(2-sided)
Exact Sig.
(1-sided)
Computed only for a 2x2 tablea. 
3 cells (75.0%) have expected count less than 5. The minimum expected count is .
13.
b. 
arytenoid.R * p arytenoid.H Crosstabulation
6 7 13
19.4% 22.6% 41.9%
2 16 18
6.5% 51.6% 58.1%
8 23 31
25.8% 74.2% 100.0%
Count
% of Total
Count
% of Total
Count
% of Total
Yes
No
arytenoid.R
Total
Yes No
p arytenoid.H
Total
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Sensitivity- 75% 
Specificity- 69.5% 
PPV- 46% 
 
  
Chi-Square Tests
1.975b 1 .160
.585 1 .444
1.698 1 .193
.212 .212
1.911 1 .167
31
Pearson Chi-Square
Continuity Correctiona
Likelihood Ratio
Fisher's Exact Test
Linear-by-Linear
Association
N of Valid Cases
Value df
Asymp. Sig.
(2-sided)
Exact Sig.
(2-sided)
Exact Sig.
(1-sided)
Computed only for a 2x2 tablea. 
2 cells (50.0%) have expected count less than 5. The minimum expected count is .
90.
b. 
thyroid.R * p thyroid .H Crosstabulation
16 2 18
51.6% 6.5% 58.1%
6 7 13
19.4% 22.6% 41.9%
22 9 31
71.0% 29.0% 100.0%
Count
% of Total
Count
% of Total
Count
% of Total
Yes
No
thyroid.R
Total
Yes No
p thyroid .H
Total
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Sensitivity – 72.7% 
Specificity- 77.7% 
PPV         - 88.8% 
 
 
  
Chi-Square Tests
6.691b 1 .010
4.777 1 .029
6.849 1 .009
.017 .014
6.475 1 .011
31
Pearson Chi-Square
Continuity Correctiona
Likelihood Ratio
Fisher's Exact Test
Linear-by-Linear
Association
N of Valid Cases
Value df
Asymp. Sig.
(2-sided)
Exact Sig.
(2-sided)
Exact Sig.
(1-sided)
Computed only for a 2x2 tablea. 
1 cells (25.0%) have expected count less than 5. The minimum expected count is 3.
77.
b. 
cricoid.R * p cricoid.H Crosstabulation
2 2 4
6.5% 6.5% 12.9%
5 22 27
16.1% 71.0% 87.1%
7 24 31
22.6% 77.4% 100.0%
Count
% of Total
Count
% of Total
Count
% of Total
Yes
No
cricoid.R
Total
Yes No
p cricoid.H
Total
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Sensitivity – 28% 
Specificity- 91% 
PPV         - 50% 
 
 
  
Chi-Square Tests
1.975b 1 .160
.585 1 .444
1.698 1 .193
.212 .212
1.911 1 .167
31
Pearson Chi-Square
Continuity Correctiona
Likelihood Ratio
Fisher's Exact Test
Linear-by-Linear
Association
N of Valid Cases
Value df
Asymp. Sig.
(2-sided)
Exact Sig.
(2-sided)
Exact Sig.
(1-sided)
Computed only for a 2x2 tablea. 
2 cells (50.0%) have expected count less than 5. The minimum expected count is .
90.
b. 
subglottis.R * p subglottis.H Crosstabulation
10 0 10
32.3% .0% 32.3%
7 14 21
22.6% 45.2% 67.7%
17 14 31
54.8% 45.2% 100.0%
Count
% of Total
Count
% of Total
Count
% of Total
Yes
No
subglottis.R
Total
Yes No
p subglottis.H
Total
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Sensitivity – 58.8% 
Specificity- 100% 
PPV        - 100% 
 
 
 
  
Chi-Square Tests
12.157b 1 .000
9.614 1 .002
15.951 1 .000
.000 .000
11.765 1 .001
31
Pearson Chi-Square
Continuity Correctiona
Likelihood Ratio
Fisher's Exact Test
Linear-by-Linear
Association
N of Valid Cases
Value df
Asymp. Sig.
(2-sided)
Exact Sig.
(2-sided)
Exact Sig.
(1-sided)
Computed only for a 2x2 tablea. 
1 cells (25.0%) have expected count less than 5. The minimum expected count is 4.
52.
b. 
paraglottic.R * p paraglottic.H Crosstabulation
24 1 25
77.4% 3.2% 80.6%
3 3 6
9.7% 9.7% 19.4%
27 4 31
87.1% 12.9% 100.0%
Count
% of Total
Count
% of Total
Count
% of Total
Yes
No
paraglottic.R
Total
Yes No
p paraglottic.H
Total
62 
 
Sensitivity- 88.8% 
Specificity- 75% 
PPV- 96% 
 
 
 
  
Chi-Square Tests
9.111b 1 .003
5.477 1 .019
7.127 1 .008
.016 .016
8.817 1 .003
31
Pearson Chi-Square
Continuity Correctiona
Likelihood Ratio
Fisher's Exact Test
Linear-by-Linear
Association
N of Valid Cases
Value df
Asymp. Sig.
(2-sided)
Exact Sig.
(2-sided)
Exact Sig.
(1-sided)
Computed only for a 2x2 tablea. 
2 cells (50.0%) have expected count less than 5. The minimum expected count is .
77.
b. 
preepiglottic sp.R * p preepiglottic.H Crosstabulation
31 31
100.0% 100.0%
31 31
100.0% 100.0%
Count
% of Total
Count
% of Total
Nopreepiglottic sp.R
Total
No
p preepiglottic.
H
Total
Chi-Square Tests
.
a
31
Pearson Chi-Square
N of Valid Cases
Value
No statistics are computed because preepiglottic
sp.R and p preepiglottic.H are constants.
a. 
63 
Pre epiglottic space 100%  specific 
 
 
PPV- 50% 
  
Chi-Square Tests
6.718b 1 .010
1.219 1 .270
3.359 1 .067
.127 .127
6.501 1 .011
31
Pearson Chi-Square
Continuity Correctiona
Likelihood Ratio
Fisher's Exact Test
Linear-by-Linear
Association
N of Valid Cases
Value df
Asymp. Sig.
(2-sided)
Exact Sig.
(2-sided)
Exact Sig.
(1-sided)
Computed only for a 2x2 tablea. 
3 cells (75.0%) have expected count less than 5. The minimum expected count is .
13.
b. 
extralaryngeal spread R & p extralaryngeal tissues.H Crosstabulation
1 1 2
3.2% 3.2% 6.5%
1 28 29 
3.2% 90.3% 93.5%
2 29 31 
6.5% 93.5% 100.0%
Count
% of Total
Count
% of Total
Count
% of Total
Yes
No
extralaryngeal
spread 
Total
Yes No
p extralaryngeal
tissues.H 
Total 
64 
 
Comparison of clinical staging T3 with CT (R) and  
Histopathology (p) 
 Clinical stageT3 * stageT3.R *( Supraglottic) 
 
Result : clinical T3 in supraglottic is 50% accurate with CT 
stageT3 * stageT3.R * transglottic 
 
  
Crosstab
5 5 10
50.0% 50.0% 100.0%
5 5 10
50.0% 50.0% 100.0%
4 16 20
19.0% 76.2% 95.2%
0 1 1
.0% 4.8% 4.8%
4 17 21
19.0% 81.0% 100.0%
Count
% of Total
Count
% of Total
Count
% of Total
Count
% of Total
Count
% of Total
YesstageT3
Total
Yes
No
stageT3
Total
Supraglottic
Yes
No
Yes No
stageT3.R
Total
Crosstab
2 12 14
14.3% 85.7% 100.0%
2 12 14
14.3% 85.7% 100.0%
7 9 16
41.2% 52.9% 94.1%
0 1 1
.0% 5.9% 5.9%
7 10 17
41.2% 58.8% 100.0%
Count
% of Total
Count
% of Total
Count
% of Total
Count
% of Total
Count
% of Total
YesstageT3
Total
Yes
No
stageT3
Total
transglottic
Yes
No
Yes No
stageT3.R
Total
65 
 
Result :Clinical T3 is only 14%  accurate with radiology in 
transglottic tumours 
Clinical stageT3 * CT stageT3.R * Glottic 
 
Result is clinical staging accuracy is 28.5 % with radiology in T3 
glottic tumours 
Clinical stageT3 * staging.PT3 * Supraglottic  
 
 
Crosstab
5 5 10 
50.0% 50.0% 100.0% 
5 5 10 
50.0% 50.0% 100.0% 
3 17 20 
14.3% 81.0% 95.2%
0 1 1
.0% 4.8% 4.8%
3 18 21 
14.3% 85.7% 100.0% 
Count
% of Total
Count
% of Total
Count
% of Total
Count
% of Total
Count
% of Total
YesstageT3
Total
Yes
No
stageT3
Total
Supraglottic
Yes 
No
Yes No
staging.PT3
Total
Crosstab
2 4 6
25.0% 62.5% 87.5%
0 1 1
.0% 12.5% 12.5%
2 5 7
25.0% 75.0% 100.0%
7 17 24 
30.4% 69.6% 100.0%
7 17 24 
30.4% 69.6% 100.0%
Count 
% of Total
Count 
% of Total
Count 
% of Total
Count 
% of Total
Count 
% of Total
Yes
No
stageT3
Total
YesstageT3
Total
Glottic
Yes 
No
Yes No 
stageT3.R
Total
66 
Result: clinical T3 is 50% accurate with pT3 supraglottic 
Clinical stageT3 * staging.PT3 * transglottic 
 
Result : 14% accuracy in transglottic T3 
Clinical stageT3 * staging.PT3 * Glottic 
 
  
Crosstab
2 12 14
14.3% 85.7% 100.0%
2 12 14
14.3% 85.7% 100.0%
6 10 16
35.3% 58.8% 94.1%
0 1 1
.0% 5.9% 5.9%
6 11 17
35.3% 64.7% 100.0%
Count
% of Total
Count
% of Total
Count
% of Total
Count
% of Total
Count
% of Total
YesstageT3
Total
Yes
No
stageT3
Total
transglottic
Yes
No
Yes No
staging.PT3
Total
Crosstab
2 4 6
25.0% 62.5% 87.5%
0 1 1
.0% 12.5% 12.5%
2 5 7
25.0% 75.0% 100.0%
6 17 23 
26.1% 73.9% 100.0%
6 17 23 
26.1% 73.9% 100.0%
Count
% of Total
Count
% of Total
Count
% of Total
Count
% of Total
Count
% of Total
Yes
No
stageT3
Total
YesstageT3
Total
Glottic
Yes 
No
Yes No 
staging.PT3
Total
67 
 
Clinical glottis T3 vs pT3 is 33% accurate 
CT(R) T3 Vs Histopathological PT3 supraglottic 
 
Result CT T3 stage is 80% accurate with pT3 
stageT3.R * staging.PT3 * transglottic 
 
Most of the cases of clinical T3 transglottic became radiological T4 
so the table becomes statistically insignificant. 
stageT3.R * staging.PT3 * Supraglottic Crosstabulation
4 1 5
40.0% 10.0% 50.0%
1 4 5
10.0% 40.0% 50.0%
5 5 10
50.0% 50.0% 100.0%
1 3 4
4.8% 14.3% 19.0%
2 15 17
9.5% 71.4% 81.0%
3 18 21
14.3% 85.7% 100.0%
Count
% of Total
Count
% of Total
Count
% of Total
Count
% of Total
Count
% of Total
Count
% of Total
Yes
No
stageT3.R
Total
Yes
No
stageT3.R
Total
Supraglottic
Yes
No
Yes No
staging.PT3
Total
Crosstab
0 2 2
.0% 14.3% 14.3%
2 10 12
14.3% 71.4% 85.7%
2 12 14
14.3% 85.7% 100.0%
5 2 7
29.4% 11.8% 41.2%
1 9 10
5.9% 52.9% 58.8%
6 11 17
35.3% 64.7% 100.0%
Count
% of Total
Count
% of Total
Count
% of Total
Count
% of Total
Count
% of Total
Count
% of Total
Yes
No
stageT3.R
Total
Yes
No
stageT3.R
Total
transglottic
Yes
No
Yes No
staging.PT3
Total
68 
stageT3.R * staging.PT3 * Glottic 
 
Result CT glottis T3 is 25 % accurate and 50% sensitive 
Clinical stageT4a * CT stageT4.R * Supraglottic 
 
 
 
 
Crosstab
5 5 10
50.0% 50.0% 100.0%
5 5 10
50.0% 50.0% 100.0%
1 0 1
4.8% .0% 4.8%
16 4 20
76.2% 19.0% 95.2%
17 4 21
81.0% 19.0% 100.0%
Count
% of Total
Count
% of Total
Count
% of Total
Count
% of Total
Count
% of Total
NostageT4a
Total
Yes
No
stageT4a
Total
Supraglottic
Yes
No
Yes No
stageT4.R
Total
Crosstab 
1 3 4
12.5% 12.5% 25.0%
1 2 3
12.5% 62.5% 75.0%
2 5 8
25.0% 75.0% 100.0%
4 3 7
17.4% 13.0% 30.4%
2 14 16 
8.7% 60.9% 69.6%
6 17 23 
26.1% 73.9% 100.0%
Count
% of Total
Count
% of Total
Count
% of Total
Count
% of Total
Count
% of Total
Count
% of Total
Yes 
No
stageT3.R
Total
Yes 
No
stageT3.R
Total
Glottic
Yes 
No
Yes No
staging.PT3 
Total
69 
Result : 50% accuracy 
clinical stageT4a *  CT stageT4.R * transglottic 
 
Only one clinical T4a case is present so comparision is 
statistically will not produce any meaning full result but in gross 
most of the cases are underestimated 
Clinical stageT4a *CT  stageT4.R * Glottic 
 
  
Crosstab
12 2 14
85.7% 14.3% 100.0%
12 2 14
85.7% 14.3% 100.0%
1 0 1
5.9% .0% 5.9%
9 7 16
52.9% 41.2% 94.1%
10 7 17
58.8% 41.2% 100.0%
Count
% of Total
Count
% of Total
Count
% of Total
Count
% of Total
Count
% of Total
NostageT4a
Total
Yes
No
stageT4a
Total
transglottic
Yes
No
Yes No
stageT4.R
Total
Crosstab
1 0 1 
12.5% .0% 12.5%
5 1 6 
62.5% 25.0% 87.5%
6 1 7 
75.0% 25.0% 100.0% 
16 8 24 
69.6% 30.4% 100.0% 
16 8 24 
69.6% 30.4% 100.0% 
Count
% of Total
Count
% of Total
Count
% of Total
Count
% of Total
Count
% of Total
Yes
No
stageT4a
Total
NostageT4a
Total
Glottic
Yes 
No
Yes No
stageT4.R
Total
70 
 
Result : 14% accurate 
Clinical stageT4a *  histopathology staging.PT4 * Supraglottic 
 
Result : 50% accurate  
Clinical stageT4a *  histopathological staging.PT4 * 
transglottic 
 
 
 
Crosstab
5 5 10
50.0% 50.0% 100.0%
5 5 10
50.0% 50.0% 100.0%
1 0 1
4.8% .0% 4.8%
17 3 20
81.0% 14.3% 95.2%
18 3 21
85.7% 14.3% 100.0%
Count
% of Total
Count
% of Total
Count
% of Total
Count
% of Total
Count
% of Total
NostageT4a
Total
Yes
No
stageT4a
Total
Supraglottic
Yes
No
Yes No
staging.PT4
Total
Crosstab
12 2 14
85.7% 14.3% 100.0%
12 2 14
85.7% 14.3% 100.0%
1 0 1
5.9% .0% 5.9%
10 6 16
58.8% 35.3% 94.1%
11 6 17
64.7% 35.3% 100.0%
Count
% of Total
Count
% of Total
Count
% of Total
Count
% of Total
Count
% of Total
NostageT4a
Total
Yes
No
stageT4a
Total
transglottic
Yes
No
Yes No
staging.PT4
Total
71 
Result : only 14% accurate 
Clinical stageT4a *  histopathological staging.PT4 * Glottic 
 
Result : only one case of clinical T4a which was accurate. 
CT stageT4.R * staging.PT4 * Supraglottic 
 
  
Crosstab
4 1 5
40.0% 10.0% 50.0%
1 4 5
10.0% 40.0% 50.0%
5 5 10
50.0% 50.0% 100.0%
15 2 17
71.4% 9.5% 81.0%
3 1 4
14.3% 4.8% 19.0%
18 3 21
85.7% 14.3% 100.0%
Count
% of Total
Count
% of Total
Count
% of Total
Count
% of Total
Count
% of Total
Count
% of Total
Yes
No
stageT4.R
Total
Yes
No
stageT4.R
Total
Supraglottic
Yes
No
Yes No
staging.PT4
Total
Crosstab
1 0 1 
12.5% .0% 12.5%
5 1 6 
62.5% 25.0% 87.5%
6 1 7 
75.0% 25.0% 100.0% 
17 7 24 
73.9% 26.1% 100.0% 
17 7 24 
73.9% 26.1% 100.0% 
Count
% of Total
Count
% of Total
Count
% of Total
Count
% of Total
Count
% of Total
Yes
No
stageT4a
Total
NostageT4a
Total
Glottic
Yes 
No
Yes No
staging.PT4 
Total
72 
Result : 80% accurate 
CT stageT4.R * staging.PT4 * transglottic 
 
Result :83 % accurate 
stageT4a.R * staging.PT4 * Glottic 
Result :  83% accurate 
 
 
Crosstab
10 2 12
71.4% 14.3% 85.7%
2 0 2
14.3% .0% 14.3%
12 2 14
85.7% 14.3% 100.0%
9 1 10
52.9% 5.9% 58.8%
2 5 7
11.8% 29.4% 41.2%
11 6 17
64.7% 35.3% 100.0%
Count
% of Total
Count
% of Total
Count
% of Total
Count
% of Total
Count
% of Total
Count
% of Total
Yes
No
stageT4.R
Total
Yes
No
stageT4.R
Total
transglottic
Yes
No
Yes No
staging.PT4
Total
Crosstab 
5 1 6
62.5% 12.5% 75.0%
1 0 1
12.5% 12.5% 25.0%
6 1 7
75.0% 25.0% 100.0%
14 2 16 
60.9% 8.7% 69.6%
3 5 8
13.0% 17.4% 30.4%
17 7 24 
73.9% 26.1% 100.0%
Count
% of Total
Count
% of Total
Count
% of Total
Count
% of Total
Count
% of Total
Count
% of Total
Yes 
No
stageT4.R
Total
Yes 
No
stageT4.R
Total
Glottic
Yes 
No
Yes No
staging.PT4 
Total
73 
 
 
Result – 1/7 cases of selective neck dissection had recurrence 
Supraglottic * Nodal Recurrence 
30% of cases have nodal recurrence. Of these cases one clinically 
N1 neck not done  Selective Neck Dissection. 
 
Transglottic * Nodal Recurrence 
29 % of Clinically N0 neck have recurrence in transglottic tumours  
SND * Nodal Recurrence Crosstabulation
1 6 7
3.2% 19.4% 22.6%
6 18 24
19.4% 58.1% 77.4%
7 24 31
22.6% 77.4% 100.0%
Count
% of Total
Count
% of Total
Count
% of Total
Yes
No
SND
Total
Yes No
Nodal Recurrence
Total
Crosstab
3 7 10
9.7% 22.6% 32.3%
4 17 21
12.9% 54.8% 67.7%
7 24 31
22.6% 77.4% 100.0%
Count
% of Total
Count
% of Total
Count
% of Total
Yes
No
Supraglottic
Total
Yes No
Nodal Recurrence
Total
74 
 
 
Glottic * Nodal Recurrence 
There are no nodal recurrence in glottis cases.  
Supraglottic * Selective Neck Dissection 
50% of cases of supraglottic tumours underwent selective neck 
dissection of which one had nodal recurrence. 
 
Transglottic * Selective Neck Dissection 
14 % of clinically N0 neck have been done selective neck 
dissections. 
Crosstab
4 10 14
12.9% 32.3% 45.2%
3 14 17
9.7% 45.2% 54.8%
7 24 31
22.6% 77.4% 100.0%
Count
% of Total
Count
% of Total
Count
% of Total
Yes
No
transglottic
Total
Yes No
Nodal Recurrence
Total
Crosstab
5 5 10
16.1% 16.1% 32.3%
2 19 21
6.5% 61.3% 67.7%
7 24 31
22.6% 77.4% 100.0%
Count
% of Total
Count
% of Total
Count
% of Total
Yes
No
Supraglottic
Total
Yes No
SND
Total
75 
 
 
Glottic * Selective Neck Dissection 
No cases  
 
                                  
                                    
 
 
 
 
 
 
 
Crosstab
2 12 14
6.5% 38.7% 45.2%
5 12 17
16.1% 38.7% 54.8%
7 24 31
22.6% 77.4% 100.0%
Count
% of Total
Count
% of Total
Count
% of Total
Yes
No
transglottic
Total
Yes No
SND
Total
76 
 
RESULTS OF STATISTICAL ANALYSIS 
Total no . of cases of  total laryngectomy - 31  
Mean age of the study population-             56 
96.8% of the study population are male 
1 Female case is of supraglottic tumor without neck dissection and 
recurrence. 
Tumor location : 
1. Supraglottic tumours -32.3% ( 10 cases) 
2. Transglottic               - 45.2% (14 cases) 
3. Glottic                       - 25.8% ( 7 cases) 
Variables of clinical staging that were comparable were arytenoids, 
anterior commisure and subglottis, nodalstatus, T stage 
Clinical evaluation Radiological 
evaluation(CT) 
Histopathology 
(comparing 
variables with CT) 
Arytenoids – 7(22%) Arytenoids– 13 
( 41.9%) 
8(25.8%) 
Marginal zone – 10(32.3%) Anterior comm.-
19(61.2%)  
19(61.3%) 
Ant.commissure- 17(54.8%) Paraglottic space-
25(80.6%) 
27(87.1%) 
Ventricle – 24 (77.4%) Preepiglottic space-0 0 
Subglottis- 4 (12.9%) Subglottis-   17 (54.8%) 
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10(32.3%) 
Extra laryngeal spread – 1 
(3%) 
Extra laryngeal 
spread-2(6.5%) 
1(3.2%) 
 Thyroid cartilage-
18(58.1) 
22(71%) 
 Cricoids cartilage-
4(41.9%) 
7(22.6%) 
T3 – 30(96.8) T3- 9 (29%) 8(25.8) 
T4a- 1(3.2) T4a- 22(71%) 23(74.2) 
N0 – 30 (96.8) N0- 30 6/7 
N1- 1 (3.2) N1- 1 1/7 
N2- 0 N2-0 0 
  
 Total number of selective neck dissections were 7.  
 30 cases out of 31 had total thyroidectomy done of 
which one case of transglottic tumour was reported to have 
papillary ca. thyroid infiltrating larynx. 
 one case of hemithyoidectomy done without any 
tumour involvement. 
 Total nodal recurrences with minimum 6 months 
follow up were 7 / 31 of which 3/7 were supraglottic and 4/7 were 
transglottic. One of 3 nodal recurrence of  supraglottic tumour 
came even after the selective neck dissection on the same side and 
from one N1 neck which neck was not surgically operated. 
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Comparative results of CT  with  histopathological findings: 
CT  results Sensitivity % Specificity % PPV % 
Ant.commissure 100 66 82.6 
Arytenoids 75 69.5 46 
Thyroid 72.7 77.7 88.8 
Cricoids 28 91 50 
Subglottis 58.8 100 100 
Paraglottic space 88.8 75 96 
Preepiglottic 
space 
No involvement 
in any case 
100  
Extra laryngeal 
tissue spread 
100 100 100 
 
CT  sensitivity  of tumour involvement in descending order in 
comparison with histopathology 
 Ant. Commissure> paraglottic space > arytenoids> 
thyroid cartilage > subglottis > cricoids 
 30% of supraglottic tumours and 28.5% transglottic 
tumours with most of them with clinically N0 neck had nodal 
recurrences  
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Clinical Staging  Vs Histopathological Staging 
Tumour location Under estimation Accurate Over estimation 
Supraglottic  5 5 Nil 
Transglottic  11 3 Nil 
Glottis  5 2 Nil 
Total  21/31 10 Nil 
% 70% 33%  
 
Radiological Staging Vs Histopathological Staging 
Tumour location Under estimation Accurate  Over estimation 
Supraglottic  1 8 1 
Transglottic  2 10 2 
Glottis  3 3 1 
Total  6 21 4 
% 19% 67% 13% 
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DISCUSSION 
Clinical staging alone in advanced laryngeal tumours has failed to 
correctly estimate true limits of tumour in large percentage of cases. In 
our present study accurate clinical staging done in 10 out of 31 cases 
(33%).Accuracy of CT scan imaging overall in tumour staging in our 
study is  (83%).  These findings are quite similar to those reported  by  
 
S.No Year Author Comparision of Results 
Literature  
My Study 
 
                  Accuracy of staging 
 
  clinical CT clinical CT 
1. 1986 Pillsbury and 
kirchner 
43% 76% 33% 83% 
2. 1986 Katasonis et al 62% 82%   
3. 1991 Vogl et al 54% 84%   
4. 1989 Sulfaro et al 49% 71%   
5. 1996 Thabet et al 52% 68%   
6. 1996 Becker  58%    
7. 1997 zbaren 57%    
8. 1999 Ferri T 51% 70%   
 
Pillsbury and Kirchner (clinical 43%), Katsantonis et al (1986), 
who reported preoperative CT and clinical staging accuracy of 82%, 
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62%, respectively. Vogl et al (1991)  reported preoperative clinical 
staging accuracy of 54% for laryngeal carcinomas. This is little different 
from that obtained by Sulfaro et al (1989) , who found the accuracy of 
the clinical vs CT staging for laryngeal carcinomas was 49% , 71% 
respectively. Thabet et al (1996), reported overall accuracy  by clinical 
evaluation  52% and CT scan 68%. Becker (1997) ,and Zbaren (1996)  
reported preoperative clinical staging accuracy for laryngeal carcinomas 
of 58%  57.5% respectively. Ferri T(1999)  found the staging accuracy 
of  laryngoscopy vs CT scan was 51.3% , 70.1%, respectively.  
Differences in our results from those of previous studies might be 
explained by the presence of a large number of superficial and small 
mucosal tumors in their series which lowered CT accuracy.  
Evaluation of clinical tumour staging accuracy stratified by  
tumour location.  In  our study low accuracy in staging glottis tumours 
35%. This does not agree  with by Thabet et al (1996)  ,who reported 
similar results and found high accuracy in staging glottic tumours (85%) 
by clinical evaluation. Katsantonis et al (1986)  who reported a very 
reliable clinical staging for glottic tumours, offering 93% accuracy. In 
our study all our glottis tumours are of advanced stage with involvement 
of cartilage so clinical accuracy is very much low.  
 In our series we found lower accuracy in staging supraglottic 
tumours was (50%). Thabet et al (1996),Katsantonis et al (1986) 
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reported preoperative clinical staging accuracy of 45%, 74% for 
supraglottic tumours respectively. In our series, the accuracy of clinical 
evaluation in staging transglottic tumours was (20%). This is not 
comparable with that of by Katsantonis et al , who found clinical 
evaluation accuracy of 45% for transglottic tumours , but comparable 
with that obtained by Thabet et al  ,who reported very low accuracy in 
staging transglottic tumours (31%).  
 In our series, we found by means tumour location there was very 
high accuracy in staging supraglottic and transglottic ,glottis tumours 
(80%), (85%), (85%) respectively in comparison with histopathological 
staging: Katsantonis et al (1986) showed also high CT scan staging 
accuracy of 83% for supraglottic, and 88% for transglottic tumors. 
Thabet et al (1996) reported  preoperative CT staging accuracy of 68% 
for supraglottic, and 88% for transglottic tumors. Katsantonis et al 
(74%), and higher than Thabet et al (1996) who reported lower accuracy 
(46%) in staging glottic tumors. In our series the clinical staging 
accuracy decreased from  supraglottic to glottic to transglottic tumors, 
whereas CT scan staging became significantly more in transglottic and 
similar in glottis and supraglottic tumours . Similar results observed by 
Katsantonis et al (1986), Ferri T (1999), Thabet et al (1996).  
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All clinical/ endoscopic staging errors consisted of an 
underestimation that resulted from a failure to identify involvement of 
paraglottis, preepiglottic space and destruction of laryngeal cartilage with 
extralaryngeal tumour invasion. So many pT4 tumours were 
underestimated clinically. Detection of cartilage involvement is important 
since it precludes laryngeal conservation surgery in many cases and is 
associated with risk of necrosis, perichondritis and tissue edema with 
radiotherapy.     
In our study underestimation staging by clinical evaluation is  
70%. Harrison (1970)  ,reported clinical evaluation underestimation of 
the lesion extent in 40% of his patients. Pillsbury and Kirchner (1979) 
reported underestimation of  40% of all tumors in their series, including . 
Sulfaro et al (1989) reported underestimation for 51% of laryngeal 
tumours. In Thabet et al (1996) underestimation for all tumors was 58% 
. In our study radiological underestimation is 19% and over estimation is 
13%.   This is comparable to results obtained by: Katsantonis et al 
(1986) , and less than that reported by  Thabet et al, understaging in 
20% of cases and overstaging in 12% of cases. In our series, CT scan 
was taken about two weeks after biopsy. 
The anterior commisure and the subglottic region are often hidden 
by bulky tumours evaluating endoscopically. It is the preferential way for 
cancer extension to the anterior angle of thyroid cartilage, to the 
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subglottic wedge space and to the cricothyroid membrane. In our study 
anterior commisure involvement is missed by endoscopy in 2 cases and 
all the 2 missed cases were diagnosed by CT. Sensitivity is 100% and 
specificity is 66% by CT imaging. The results are similar with Zbaren 
M.Becker et al (1997) .  
CT sensitivity of paraglottic space is 88 %. Results are similar and 
comparable with KirchnerJA, Cornog JL, Holmes study (1987). 
Tumours arising in the ventricle  invade first in the paraglottic space and 
then both the supraglottic and subglottic region which are missed by 
endoscopic evaluation. 
Pre epiglottic space was not involved in any of the cases and CT 
was with 100% specificity. Our results are slightly better for these spaces 
than given in literature. 
          According to literature, CT accurately demonstrates gross 
cartilage invasion, but fails to detect minor invasion in many cases.  This 
has been proved in study done by Becker  M, Zbaren P (1995).  The 
ability of CT to detect tumour invasion in cartilage varies with reported 
sensitivities of 46 to 66 percentages and specificities of 84 to 94 
percentage(Becker M, Zbaren P ). In our study it is sensitivity of Thyroid 
cartilage 72.7%, cricoid cartilage 28%, Arytenoid cartilage 75%.  The 
irregular pattern of Thyroid cartilage calcification doesnot match with 
tumour invasion nor normal and pathology cartilage differentiated on 
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basis of density values(Hoover LA, Calcaterra, 1984 study).  Arytenoid 
and Cricoid cartilage however can show a symmetric irregular sclerosis 
that suggest cartilage invasion.  MRI shows nonossified and ossified  
cartilage better than CT.  In the literature overall sensitivity of MRI in 
detection of neoplastic cartilage invasion is 89% and specificity between 
82%-88%.  Although MRI has better sensitivity it has low specificity due 
to severe inflammatory changes, fibrosis and extra medullary 
hematopoiesis within the cartilage that result in high false positive rate.  
In contrast CT has high false negative rate. 
Among the 31 cases clinically N0-30, N1-1. Nodal metastasis is 
reported only in one case of supraglottic tumor and patient was not 
treated for neck surgically was sent to radiotherapy after laryngectomy 
had recurrence of node in the same side of the tumor within 6 months.  
Other 6 cases of nodal recurrence were two supraglottic and four 
transglottic tumors.  Among the seven cases, one case of selective neck 
dissection of supraglottic tumor had nodal recurrence.  Glottic tumors did 
not have any nodal recurrence.  Selective neck dissection was done for 7 
cases.  5 supraglottic, 2 transglottic tumors.  Our study shows out of 24 
cases of Supraglottic and Transglottic tumors with mostly N0 neck had 7 
nodal Recurrences (29%) after Surgery+Radiotherapy.  
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LIMITATIONS OF STUDY 
1. Tracheostomy whether done or not is not taken into 
consideration. 
2. Tumour volume / thickness or depth not assessed. 
3. Delay of 1- 2 weeks of time between surgery and CT evaluation. 
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CONCLUSION 
 
The accuracy of clinical staging in our study of advanced stage 
laryngeal tumours  decreased from supraglottic to glottic to transglottic 
tumours.  
Conversely, the staging accuracy of sectional imaging is best in 
transglottic tumours and similar supraglottic tumours  and glottic 
tumours. 
 There is gross underestimation of T4a cases clinically, almost 67% 
. With the help of CT underestimation of T4a cases have come down to 
17%. CT therefore prevented most of the clinically underestimated cases 
from undergoing unnecessary organ preservation modalities like 
chemoradiotherapy and then salvage Total Laryngectomy.  
Further CT helped in identifying thyroid  cartilage invasion 
accurately in 73% of cases which has aided immensely in treatment 
planning. With addition of MRI,  accuracy could still improve and aid in 
reducing underestimation of cases.  
Nodal recurrences in N0 neck shows CT fails to identify early 
nodal metastasis.        
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